Prognostic value of DNA ploidy and S-phase fraction in relation to estrogen receptor content and clinicopathological variables in primary breast cancer.

[1]  O. Kallioniemi,et al.  Tumour DNA ploidy as an independent prognostic factor in breast cancer. , 1987, British Journal of Cancer.

[2]  R. Gelber,et al.  Association of DNA index and S-phase fraction with prognosis of nodes positive early breast cancer. , 1987, Cancer research.

[3]  H. Bojar,et al.  Differentiated DNA analysis in relation to steroid receptor status, grading, and staging in human breast cancer. , 1987, Anticancer research.

[4]  A. Howell,et al.  DNA analysis by flow cytometry, response to endocrine treatment and prognosis in advanced carcinoma of the breast. , 1987, British Journal of Cancer.

[5]  O. Kallioniemi,et al.  Aneuploid DNA content and high S-phase fraction of tumour cells are related to poor prognosis in patients with primary breast cancer. , 1987, European journal of cancer & clinical oncology.

[6]  C. Cornelisse,et al.  DNA ploidy and survival in breast cancer patients. , 1987, Cytometry.

[7]  I. Ellis,et al.  Prognostic significance of the DNA content of human breast cancer , 1987, The British journal of surgery.

[8]  T. Lemarchand-Béraud,et al.  The predictive value of estrogen and progesterone receptors' concentrations on the clinical behavior of breast cancer in women °clinical correlation on 547 patients , 1986, Cancer.

[9]  Robert W. McDivitt,et al.  A proposed classification of breast cancer based on kinetic information derived from a comparison of risk factors in 168 primary operable breast cancers , 1986, Cancer.

[10]  B. Rasmussen,et al.  Steroid hormone receptors as prognostic indicators in primary breast cancer. , 1986, Breast cancer research and treatment.

[11]  L. Skoog,et al.  Proliferative index, cytosol estrogen receptor and axillary node status as prognostic predictors in human mammary carcinoma. , 1986, Breast cancer research and treatment.

[12]  M. Daidone,et al.  Cell kinetics as a prognostic marker in node‐negative breast cancer , 1985, Cancer.

[13]  L. Skoog,et al.  DNA distribution, cytosol estrogen receptors and axillary nodes as prognostic predictors in breast carcinoma. , 1985, Acta radiologica. Oncology.

[14]  D. Barnes,et al.  The effect of oestrogen and progesterone receptors on recurrence and survival in patients with carcinoma of the breast. , 1985, British Journal of Cancer.

[15]  I. Taylor,et al.  Influence of cellular DNA content on disease-free survival of Stage II breast cancer patients. , 1984, Cancer research.

[16]  M. Black,et al.  Correlation of cell‐cycle kinetics, hormone receptors, histopathology, and nodal status in human breast cancer , 1984, Cancer.

[17]  D. Seckinger,et al.  Prognostic indicators including DNA histogram type, receptor content, and staging related to human breast cancer patient survival. , 1984, Cancer research.

[18]  D. Killander,et al.  Flow‐Cytometric DNA analysis in primary breast carcinomas and clinicopthological correlations , 1984 .

[19]  S. Aamdal,et al.  Estrogen receptors and long‐term prognosis in breast cancer , 1984, Cancer.

[20]  M. Tubiana,et al.  The long‐term prognostic significance of the thymidine labelling index in breast cancer , 1984, International journal of cancer.

[21]  M. M. McCrate,et al.  Prediction of early course of breast carcinoma by thymidine labeling , 1983, Cancer.

[22]  I. Taylor,et al.  The influence of age on the DNA ploidy levels of breast tumours. , 1983, European journal of cancer & clinical oncology.

[23]  I. Christensen,et al.  A detergent-trypsin method for the preparation of nuclei for flow cytometric DNA analysis. , 1983, Cytometry.

[24]  I J Christensen,et al.  Standardization of high-resolution flow cytometric DNA analysis by the simultaneous use of chicken and trout red blood cells as internal reference standards. , 1983, Cytometry.

[25]  B. Nathwani,et al.  Flow cytometry in the diagnosis and classification of malignant lymphoma and leukemia , 1982, Cancer.

[26]  J. Spinelli,et al.  Estrogen receptor quantitation and staging as complementary prognostic indicators in breast cancer: A study of 583 patients , 1981, International journal of cancer.

[27]  J. Gustafsson,et al.  Cytosol estradiol receptor in human mammary carcinoma: an assay based on isoelectric focusing in polyacrylamide gel. , 1978, Analytical biochemistry.

[28]  David R. Cox,et al.  Regression models and life tables (with discussion , 1972 .